Accessibility Menu
 
Bio Essence logo

Bio Essence

(OTC) BIOE

Current Price$0.40
Market Cap$18.72M
Since IPO (2022)-20%
5 YearN/A
1 Year+87%
1 Month+627%

Bio Essence Financials at a Glance

Market Cap

$18.72M

Revenue (TTM)

$1.90M

Net Income (TTM)

$896.20K

EPS (TTM)

$0.02

P/E Ratio

16.95

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.40

Volume

1,062

Open

$0.40

Previous Close

$0.40

Daily Range

$0.40 - $0.40

52-Week Range

$0.05 - $0.40

BIOE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio Essence

Industry

Pharmaceuticals

Employees

4

CEO

Yin Yan, MBA

Headquarters

Irvine, CA 92618, US

BIOE Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

47%

Net Income Margin

47%

Return on Equity

0%

Return on Capital

-45%

Return on Assets

2%

Earnings Yield

5.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.72M

Shares Outstanding

46.81M

Volume

1.06K

Short Interest

0.00%

Avg. Volume

5.74K

Financials (TTM)

Gross Profit

$1.43M

Operating Income

$900.01K

EBITDA

$900.01K

Operating Cash Flow

$1.57M

Capital Expenditure

$3.00

Free Cash Flow

$1.57M

Cash & ST Invst.

$0.00

Total Debt

$1.56M

Bio Essence Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.48M

+902.6%

Gross Profit

$1.14M

+969.6%

Gross Margin

77.29%

N/A

Market Cap

$18.72M

N/A

Market Cap/Employee

$9.36M

N/A

Employees

2

N/A

Net Income

$1.03M

+3833.6%

EBITDA

$1.03M

+3953.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.56M

+42.2%

Accounts Receivable

$23.45K

+357.7%

Inventory

$0.00

N/A

Long Term Debt

$56.16K

-87.4%

Short Term Debt

$1.51M

-33.3%

Return on Assets

2.12%

N/A

Return on Invested Capital

-44.63%

N/A

Free Cash Flow

$1.24M

+193.3%

Operating Cash Flow

$1.24M

+193.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVVTFRevive Therapeutics Ltd.
$0.03-1.80%
RAFARafarma Pharmaceuticals, Inc.
$0.07-0.15%
UBQUUbiquitech Software Corp.
$0.00+0.00%
NRPRResilient Healthcare Corp
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BIRDAllbirds
$16.99+5.82%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.30+0.15%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.77-0.02%
QBTSD-Wave Quantum
$20.81+0.23%

Questions About BIOE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.